4
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6054 | GSK256066 | PDE | |
GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, >380, 000-fold selectivity versus PDE1/2/3/5/6 and >2500-fold selectivity against PDE4B versus PDE7.Phase 2. | |||
T11483 | GSK256066 Trifluoroacetate | GSK 256066 Trifluoroacetate,GSK256066 (2,2,2-trifluoroacetic acid) | PDE |
GSK 256066 Trifluoroacetate is a selective and high-affinity phosphodiesterase 4 (PDE) inhibitor (IC50: 3.2 pM for PDE4B). It can be used for the treatment of chronic obstructive pulmonary disease. | |||
T70993 | WO-459 | ||
WO-459 is a novel GPR52 agonist, dose-dependently inducing elevation of intracellular cAMP in HEK293/GPR52 cells. | |||
T70995 | GSK-256066 | ||
GSK-256066 is a PDE4 inhibitor. |